Health Condition 1: J399- Disease of upper respiratory tract, unspecified
Conditions
Interventions
None listed
Sponsors
Zydus Healthcare Limited
Eligibility
Inclusion criteria
Inclusion criteria: Data of a patient will be copied in the data collection form only if: 1. Patient had an indication for application of hypertonic saline nasal sprays, including but not limited to, e.g., viral, bacterial, or allergic rhinitis, acute or chronic rhinosinusitis 2. The patient had symptoms of nasal congestion at his/her initial visit (Visit 0) at the medical center. 3. The Total Nasal Symptom Score (TNSS) of the patient was recorded as >= 5 at visit 0. 4. The patient was eligible to receive and was prescribed Nasoclear PureHaleTM as per the physicianâ??s discretion.
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| There is no primary outcome measure nor any formal sample size calculation. Descriptive statistics will be utilized to analyze data from the data collection form.Timepoint: Baseline and Visit 1 Visit 1 can be between day 5 to day 10 after baseline visit | — |
Secondary
| Measure | Time frame |
|---|---|
| No defined secondary outcomeTimepoint: No defined secondary outcome | — |
Countries
India
Contacts
Public ContactDr Ashok Jaiswal
Zydus Healthcare Limited
Outcome results
None listed